BioChange
PrivateLast Round
Crowdfunding
Oct 1, 2021
Company Overview
BioChange is a biotechnology company that has developed a tissue regeneration technology designed to stimulate tissue repair and remodeling at the injected site.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioChange Comparables
Compare BioChange with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oral Biolife Inc. | 76% | |
| Geistlich Pharma | 74% | |
| Orthocell Ltd | 71% |
BioChange Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Oct 1, 2021 |
Key People
Founding team and executive leadership
BioChange Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Grant |
| ExitValley | Crowdfunding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
Monthly visitors increased 153% MoM, reaching 644.
- May 5, 2025
Grew 21% QoQ from 14 to 17 employees.
BioChange Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioChange's valuation, stock price, and market status.
Is BioChange a public or private company?
BioChange is a private company.
What is the current stock price of BioChange?
BioChange is a private company with no public stock price. No recent secondary market data is available.
How much is BioChange worth (valuation)?
Valuation information for BioChange is not publicly available.
Can I buy BioChange stock?
BioChange shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BioChange's last funding round?
BioChange's most recent funding round was Crowdfunding on October 1, 2021.
Who are the main investors in BioChange?
Key investors in BioChange include Israel Innovation Authority.
Will BioChange IPO soon?
No public IPO plans have been announced for BioChange.
How can I track BioChange secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioChange's secondary market activity and sign up for updates.